Search alternatives:
significant risks » significant risk (Expand Search), significant results (Expand Search), significant role (Expand Search)
risks decrease » sizes decrease (Expand Search), visits decreased (Expand Search), rivers decreased (Expand Search)
bins decrease » point decrease (Expand Search), sizes decrease (Expand Search), nn decrease (Expand Search)
significant risks » significant risk (Expand Search), significant results (Expand Search), significant role (Expand Search)
risks decrease » sizes decrease (Expand Search), visits decreased (Expand Search), rivers decreased (Expand Search)
bins decrease » point decrease (Expand Search), sizes decrease (Expand Search), nn decrease (Expand Search)
-
1
-
2
-
3
-
4
Mean values (± standard deviation) of hormonal parameters before and after CWI.
Published 2025Subjects: -
5
Mean values (± standard deviation) of electrolyte concentrations before and after CWI.
Published 2025Subjects: -
6
-
7
Mean values (± standard deviation) of liver profile parameters before and after CWI.
Published 2025Subjects: -
8
Mean values (± standard deviation) of renal profile parameters before and after CWI.
Published 2025Subjects: -
9
Mean values (± standard deviation) of lipid profile parameters before and after CWI.
Published 2025Subjects: -
10
Mean values (± standard deviation) of CK, CK-MB and LDH before and after CWI.
Published 2025Subjects: -
11
-
12
-
13
Subgroup Analysis of Sleep Duration and Cardiovascular Disease Risk in Type 2 Diabetes Patients.
Published 2025Subjects: -
14
Related inflammation evaluation indexes before and after operation (mean±standard deviation).
Published 2024Subjects: -
15
-
16
-
17
-
18
Relevant follow-up evaluation indicators after operation (mean±standard deviation)/n (%).
Published 2024Subjects: -
19
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
20
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”